Janis Morgenthaler

University of Cologne

Papers

2

Total Citations

58

H-Index

2

About

Janis Morgenthaler is a radiation oncologist whose research sits at the intersection of advanced radiotherapy techniques and immunotherapy, with a particular focus on improving outcomes for patients with challenging malignancies. Her most cited work, a 2018 study on robotic stereotactic radiosurgery in melanoma patients with brain metastases receiving simultaneous anti-PD-1 treatment, has garnered 45 citations and addresses the high-interest area of combining radiotherapy with immune checkpoint inhibition. This work examines imaging findings, acute toxicity, and local control, providing critical insights into a synergistic treatment paradigm. Morgenthaler also explores the frontiers of stereotactic body radiotherapy as an alternative to brachytherapy, as demonstrated in her 2020 study on long-term results for cervical cancer patients unsuitable for brachytherapy—a niche but impactful contribution cited 13 times. Her research is characterized by a focus on precision, toxicity mitigation, and expanding treatment options for patients with limited alternatives. By bridging the gap between cutting-edge technology and clinical application, Morgenthaler is helping to shape modern, personalized radiation oncology strategies.

Research Focus

Key Achievements

2
H-Index
2
Papers
58
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment
45 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: University of Cologne

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago